{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:13:35Z","timestamp":1761185615115,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.parkreldis.2020.02.012","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T11:33:21Z","timestamp":1583148801000},"page":"80-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia"],"prefix":"10.1016","volume":"72","author":[{"given":"Carlo","family":"Civardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Collini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Geda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2020.02.012_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2016.11.012","article-title":"Oculogyric crises: etiology, pathophysiology and therapeutic approaches","volume":"36","author":"Barow","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2020.02.012_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00228-016-2024-2","article-title":"Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series","volume":"72","author":"Pasina","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.parkreldis.2020.02.012_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.parkreldis.2020.02.012_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1528-1157.1998.tb01452.x","article-title":"Semiological seizure classification","volume":"39","author":"L\u00fcders","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2020.02.012_bib5","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.neuropharm.2011.12.029","article-title":"Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations","volume":"62","author":"Nikolaev","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.parkreldis.2020.02.012_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12011-015-0268-9","article-title":"Magnesium supplementation prevents and reverses experimentally induced movement disturbances in rats: biochemical and behavioral parameters","volume":"166","author":"Kronbauer","year":"2015","journal-title":"Biol. Trace Elem. Res."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020300420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020300420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:19:00Z","timestamp":1761178740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020300420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":6,"alternative-id":["S1353802020300420"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.012","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}